Clinical Trials Browser

Terminated × Epilepsy × Clear all

NCT04485104 2025-10-31

Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures

Phase 3 Terminated

3 enrolled 28 charts

Tuberous Sclerosis 1, Tuberous Sclerosis 2, Epilepsy, Epilepsies, Myoclonic, Seizures, Spasms, Infantile, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT02134067 2024-09-05

Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors

Phase 1 Terminated

Epilepsy, Neoplasms

NCT04650204 2023-06-22

Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy

Phase 4 Terminated

4 enrolled 9 charts

Drug Resistant Epilepsy, Epilepsy, Glioma

NCT03886753 2020-07-30

Ilera

Classical hematology

Autism Spectrum Disorder, Acquired Immunodeficiency Syndrome, Anemia, Sickle Cell, Epilepsy, Glaucoma, Huntington Disease, Multiple Sclerosis, Muscle Spasticity, Neoplasms, Pain, Intractable, Parkinson Disease, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Dyskinesias

NCT01545518 2014-09-01

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Phase 2 Terminated

20 enrolled 3 charts

Drug Resistant Epilepsy, Autoimmune Diseases, Epilepsy, Epilepsies, Partial, Autoimmune Diseases of the Nervous System, Limbic Encephalitis